Noriaki Tatsuta

age ~60

from Lexington, MA

Also known as:
  • Noriaki A
Phone and address:
60 Fifer Ln, Lexington, MA 02420

Noriaki Tatsuta Phones & Addresses

  • 60 Fifer Ln, Lexington, MA 02420
  • 132 Lowell St, Lexington, MA 02420 • 7818626118
  • 425 Woburn St, Lexington, MA 02420
  • 132 Lowell St, Lexington, MA 02420

Work

  • Company:
    Synta pharmaceuticals
    Sep 2006
  • Position:
    Sr. director

Education

  • Degree:
    Ph.D.
  • School / High School:
    Kyushu University
    1977 to 1999
  • Specialities:
    Pharmaceutical

Skills

Drug Metabolism • Bioanalysis • Pharmacokinetics • Dmpk • Glp • Medicinal Chemistry • Drug Discovery • Adme • Lc Ms • Lead Optimization • Validation • Chemistry • Synthetic Chemistry • Lims • Pharmaceutical Research • Clinical Development • Pharmaceutical Industry • Toxicology • Drug Development • Lifesciences • Hplc • Ind • Oncology • Cro • Lead Change • Life Sciences • Pharmacology • Biotechnology • Sop • R&D • In Vivo • In Vitro • Cro Management • Good Laboratory Practice • Standard Operating Procedure • Liquid Chromatography Mass Spectrometry • High Performance Liquid Chromatography

Languages

Japanese

Industries

Biotechnology

Us Patents

  • Water-Soluble Bean-Based Extracts

    view source
  • US Patent:
    6458406, Oct 1, 2002
  • Filed:
    Jan 21, 2000
  • Appl. No.:
    09/489059
  • Inventors:
    Mitsunori Ono - Lexington MA 02420
    Keizo Koya - Brookline MA 02446
    Noriaki Tatsuta - Lexington MA 02420
    Naoto Yamaguchi - Lexington MA 02421
    Lan Bo Chen - Lexington MA 02420
  • International Classification:
    A23L 120
  • US Classification:
    426634, 426629, 426655, 426539, 426594, 426599, 426590, 426 3, 426631
  • Abstract:
    This invention relates to a water-soluble bean-based extract including one or more isoflavone glycosides. Also included is a method of preparing such a water-soluble bean-based extract.
  • Water-Soluble Soybean Extracts

    view source
  • US Patent:
    6541062, Apr 1, 2003
  • Filed:
    Dec 18, 2000
  • Appl. No.:
    09/739067
  • Inventors:
    Mitsunori Ono - Lexington MA 02420
    Keizo Koya - Brookline MA 02446
    Noriaki Tatsuta - Lexington MA 02420
    Naoto Yamaguchi - Lexington MA 02421
    Lan Bo Chen - Lexington MA 02420
  • International Classification:
    A23L 128
  • US Classification:
    426655, 426431, 426589, 426594, 426597, 426599, 426590, 426 3, 426631, 426634
  • Abstract:
    This invention relates to a water-soluble soybean-based extract including one or more isoflavone glycosides. Also described is a method of preparing such a water-soluble soybean-based extract.
  • Water-Soluble Bean-Based Extracts

    view source
  • US Patent:
    6616959, Sep 9, 2003
  • Filed:
    Nov 13, 2001
  • Appl. No.:
    10/006326
  • Inventors:
    Mitsunori Ono - Lexington MA 02420
    Keizo Koya - Brookline MA 02446
    Noriaki Tatsuta - Lexington MA 02420
    Naoto Yamaguchi - Lexington MA 02421
    Lan Bo Chen - Lexington MA 02420
  • International Classification:
    A23L 120
  • US Classification:
    426431, 426634, 426629, 426655, 426590
  • Abstract:
    This invention relates to a water-soluble bean-based extract including one or more isoflavone glycosides. Also shown is a method of preparing such a water-soluble bean-based extract.
  • Taxol Enhancer Compounds

    view source
  • US Patent:
    6762204, Jul 13, 2004
  • Filed:
    Jul 10, 2002
  • Appl. No.:
    10/193639
  • Inventors:
    Keizo Koya - Brookline MA
    Lijun Sun - Harvard MA
    Shoujun Chen - Billerica MA
    Noriaki Tatsuta - Lexington MA
    Yaming Wu - Lexington MA
    Mitsunori Ono - Lexington MA
    Zhi-Qiang Xia - Dedham MA
  • Assignee:
    Synta Pharmaceuticals, Inc. - Lexington MA
  • International Classification:
    A61K 3116
  • US Classification:
    514599, 564148, 564149, 564151
  • Abstract:
    One embodiment of the present invention is a compound represented by the Structural Formula (I): Y is a covalent bond of a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both C Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or âC(R R )â. R is an aliphatic group, a substituted aliphatic group, a non-aromatic heterocyclic group, or a substituted non-aromatic heterocyclic group, R -R are independently âH, an aliphatic group, a substituted aliphatic group, a non-aromatic heterocyclic group, a substituted non-aromatic heterocyclic group, an aryl group or a substituted aryl group, or R and R taken together with the carbon and nitrogen atoms to which they are bonded, and/or R and R taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. R -R are independently âH, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R and R are each independently âH, an aliphatic or substituted aliphatic group, or R is âH and R is a substituted or unsubstituted aryl group, or, R and R , taken together, are a C2-C6 substituted or unsubstituted alkylene group.
  • Taxol Enhancer Compounds

    view source
  • US Patent:
    6800660, Oct 5, 2004
  • Filed:
    Jul 10, 2002
  • Appl. No.:
    10/193075
  • Inventors:
    Keizo Koya - Brookline MA
    Lijun Sun - Harvard MA
    Shoujun Chen - Billerica MA
    Noriaki Tatsuta - Lexington MA
    Yaming Wu - Lexington MA
    Mitsunori Ono - Lexington MA
  • Assignee:
    Synta Pharmaceuticals Corp. - Lexington MA
  • International Classification:
    A61K 3116
  • US Classification:
    514614, 514615, 564148, 564149
  • Abstract:
    Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both C Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or âC(R R )â. R and R are independently an aryl group or a substituted aryl group, R and R are independently âH, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R -R are independently âH, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R and R are each independently âH, an aliphatic or substituted aliphatic group, or R is âH and R is a substituted or unsubstituted aryl group, or, R and R , taken together, are a C2-C6 substituted or unsubstituted alkylene group. Z is O or S. Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent.
  • Taxol Enhancer Compounds

    view source
  • US Patent:
    6924312, Aug 2, 2005
  • Filed:
    Jan 15, 2003
  • Appl. No.:
    10/345885
  • Inventors:
    Keizo Koya - Chestnut Hill MA, US
    Lijun Sun - Harvard MA, US
    Shoujun Chen - Bedford MA, US
    Noriaki Tatsuta - Lexington MA, US
    Yaming Wu - Lexington MA, US
    Mitsunori Ono - Lexington MA, US
  • Assignee:
    Synta Pharmaceuticals Corp. - Lexington MA
  • International Classification:
    A61K031/16
    C07C241/00
  • US Classification:
    514614, 514615, 564148, 564149
  • Abstract:
    Disclosed is a compound represented by the Structural Formula (I): Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with taxol or an analog of taxol.
  • Taxol Enhancer Compounds

    view source
  • US Patent:
    7001923, Feb 21, 2006
  • Filed:
    Mar 18, 2004
  • Appl. No.:
    10/803798
  • Inventors:
    Keizo Koya - Brookline MA, US
    Lijun Sun - Harvard MA, US
    Shoujun Chen - Billerica MA, US
    Noriaki Tatsuta - Lexington MA, US
    Yaming Wu - Lexington MA, US
    Mitsunori Ono - Lexington MA, US
    Zhi-Qiang Xia - Dedham MA, US
  • Assignee:
    Synta Pharmaceuticals Corp. - Lexington MA
  • International Classification:
    A61K 31/16
    A61K 31/335
    C07C 327/00
    C07D 305/00
  • US Classification:
    514599, 514449, 564 74, 549510
  • Abstract:
    One embodiment of the present invention is a compound represented by the Structural Formula (I): Y is a covalent bond of a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C=Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or —C(RR)—. Ris an aliphatic group, a substituted aliphatic group, a non-aromatic hetereocyclic group, or a substituted non-aromatic hetereocyclic group, R–Rare independently —H, an aliphatic group, a substituted aliphatic group, a non-aromatic hetereocyclic group, a substituted non-aromatic hetereocyclic group, an aryl group or a substituted aryl group, or Rand Rtaken together with the carbon and nitrogen atoms to which they are bonded, and/or Rand Rtaken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. R–Rare independently —H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. Rand Rare each independently —H, an aliphatic or substituted aliphatic group, or Ris —H and Ris a substituted or unsubstituted aryl group, or, Rand R, taken together, are a C2–C6 substituted or unsubstituted alkylene group.
  • Taxol Enhancer Compounds

    view source
  • US Patent:
    7037940, May 2, 2006
  • Filed:
    May 14, 2004
  • Appl. No.:
    10/846152
  • Inventors:
    Keizo Koya - Brookline MA, US
    Lijun Sun - Harvard MA, US
    Shoujun Chen - Billerica MA, US
    Noriaki Tatsuta - Lexington MA, US
    Yaming Wu - Lexington MA, US
    Mitsunori Ono - Lexington MA, US
  • Assignee:
    Synta Pharmaceuticals Corp. - Lexington MA
  • International Classification:
    A61K 31/16
    A61K 31/335
    C07C 327/00
    C07D 305/00
  • US Classification:
    514599, 514449, 564 74, 549510
  • Abstract:
    Disclosed is a compound represented by the Structural Formula (I):.

Resumes

Noriaki Tatsuta Photo 1

Head Of Drug Metabolism And Pharmacokinetics

view source
Location:
Lexington, MA
Industry:
Biotechnology
Work:
Synta Pharmaceuticals since Sep 2006
Sr. Director

Shionogi BioResearch (currently Synta Pharmaceuticals) 1997 - 2002
Scientist

Fujifilm Apr 1989 - Jul 1997
Scientist

Fuji ImmunoPharmaceuticals Corp. - Lexington, MA Aug 1995 - Jun 1997
Scientist
Education:
Kyushu University 1977 - 1999
Ph.D., Pharmaceutical
Skills:
Drug Metabolism
Bioanalysis
Pharmacokinetics
Dmpk
Glp
Medicinal Chemistry
Drug Discovery
Adme
Lc Ms
Lead Optimization
Validation
Chemistry
Synthetic Chemistry
Lims
Pharmaceutical Research
Clinical Development
Pharmaceutical Industry
Toxicology
Drug Development
Lifesciences
Hplc
Ind
Oncology
Cro
Lead Change
Life Sciences
Pharmacology
Biotechnology
Sop
R&D
In Vivo
In Vitro
Cro Management
Good Laboratory Practice
Standard Operating Procedure
Liquid Chromatography Mass Spectrometry
High Performance Liquid Chromatography
Languages:
Japanese

Facebook

Noriaki Tatsuta Photo 2

Noriaki Tatsuta

view source

Youtube

Tatsuta-no-kyoku - The Venus in Autumn

Provided to YouTube by The Orchard Enterprises Tatsuta-no-kyoku - The ...

  • Duration:
    9m 7s

SUGIYAMA Noriaki

... ( ?-20115)

  • Duration:
    3m 12s

SASUKE Ninja WarriorTBS

  • Duration:
    19m 4s

MTPC49 Start

Mahou Tsukai Pretty Cure! - Episode 49. Start on January 22, 2017. Sou...

  • Duration:
    29s

Mahou Tsukai Pretty Cure - Fully powered atta...

Mahou Tsukai Pretty Cure! - Episode 49. Soundtrack used: *Our MiracleO...

  • Duration:
    2m 24s

Mahou Tsukai Pretty Cure - Episode 49 Summary...

Mahou Tsukai Pretty Cure! - Episode 49 Summary. Vietsub by - Spirits ...

  • Duration:
    3m 24s

Googleplus

Noriaki Tatsuta Photo 3

Noriaki Tatsuta


Get Report for Noriaki Tatsuta from Lexington, MA, age ~60
Control profile